176 related articles for article (PubMed ID: 18164257)
1. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1.
Pusl T; Vennegeerts T; Wimmer R; Denk GU; Beuers U; Rust C
Biochem Biophys Res Commun; 2008 Feb; 367(1):208-12. PubMed ID: 18164257
[TBL] [Abstract][Full Text] [Related]
2. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver.
Wimmer R; Hohenester S; Pusl T; Denk GU; Rust C; Beuers U
Gut; 2008 Oct; 57(10):1448-54. PubMed ID: 18583398
[TBL] [Abstract][Full Text] [Related]
3. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
4. The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis.
Bernt C; Vennegeerts T; Beuers U; Rust C
Biochem Biophys Res Commun; 2006 Feb; 340(3):800-6. PubMed ID: 16380075
[TBL] [Abstract][Full Text] [Related]
5. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
[TBL] [Abstract][Full Text] [Related]
6. TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKCalpha-ezrin pathway.
Baiocchi L; Tisone G; Russo MA; Longhi C; Palmieri G; Volpe A; Almerighi C; Telesca C; Carbone M; Toti L; De Leonardis F; Angelico M
Transpl Int; 2008 Aug; 21(8):792-800. PubMed ID: 18435680
[TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Tauroursodeoxycholic acid on cytochrome C-mediated apoptosis in HepG2 cells].
Xie Q; Li GM; Zhou XQ; Liao D; Yu H; Guo Q
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):298-301. PubMed ID: 12773247
[TBL] [Abstract][Full Text] [Related]
11. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets.
Beuers U; Denk GU; Soroka CJ; Wimmer R; Rust C; Paumgartner G; Boyer JL
J Biol Chem; 2003 May; 278(20):17810-8. PubMed ID: 12626520
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
13. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition.
Wang L; Piguet AC; Schmidt K; Tordjmann T; Dufour JF
Hepatology; 2005 Jun; 41(6):1241-51. PubMed ID: 15861431
[TBL] [Abstract][Full Text] [Related]
14. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.
Ramalho RM; Viana RJ; Low WC; Steer CJ; Rodrigues CM
Trends Mol Med; 2008 Feb; 14(2):54-62. PubMed ID: 18218342
[TBL] [Abstract][Full Text] [Related]
15. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats.
Colak A; Kelten B; Sağmanligil A; Akdemir O; Karaoğlan A; Sahan E; Celik O; Barut S
J Clin Neurosci; 2008 Jun; 15(6):665-71. PubMed ID: 18343118
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
Fimognari C; Lenzi M; Cantelli-Forti G; Hrelia P
Ann N Y Acad Sci; 2009 Aug; 1171():264-9. PubMed ID: 19723064
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications.
Roma MG; Toledo FD; Boaglio AC; Basiglio CL; Crocenzi FA; Sánchez Pozzi EJ
Clin Sci (Lond); 2011 Dec; 121(12):523-44. PubMed ID: 21854363
[TBL] [Abstract][Full Text] [Related]
18. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
20. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
Roda A; Piazza F; Baraldini M; Speroni E; Guerra MC; Cerré C; Cantelli Forti G
Hepatology; 1998 Feb; 27(2):520-5. PubMed ID: 9462652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
